BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22842620)

  • 1. A somatic TSHR mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease.
    Kim JW; Lee S; Lui N; Choi H; Mulvihill M; Fang LT; Kang HC; Kwon YW; Jablons D; Kim IJ
    Oncol Rep; 2012 Oct; 28(4):1225-30. PubMed ID: 22842620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.
    Seki Y; Yoshida Y; Ishimine H; Shinozaki-Ushiku A; Ito Y; Sumitomo K; Nakajima J; Fukayama M; Michiue T; Asashima M; Kurisaki A
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1141-7. PubMed ID: 24380866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
    Mackinnon AC; Tretiakova M; Henderson L; Mehta RG; Yan BC; Joseph L; Krausz T; Husain AN; Reid ME; Salgia R
    J Clin Pathol; 2011 Jan; 64(1):16-24. PubMed ID: 21045234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global gene expression differentiating pure bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar carcinoma features.
    Zhang WC; Zhang ZF; You J; Wang CL
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):765-71. PubMed ID: 22864788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
    Miller VA; Riely GJ; Zakowski MF; Li AR; Patel JD; Heelan RT; Kris MG; Sandler AB; Carbone DP; Tsao A; Herbst RS; Heller G; Ladanyi M; Pao W; Johnson DH
    J Clin Oncol; 2008 Mar; 26(9):1472-8. PubMed ID: 18349398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features of lung adenocarcinoma with KRAS mutations.
    Kakegawa S; Shimizu K; Sugano M; Miyamae Y; Kaira K; Araki T; Nakano T; Kamiyoshihara M; Kawashima O; Takeyoshi I
    Cancer; 2011 Sep; 117(18):4257-66. PubMed ID: 21387273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
    Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
    Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease.
    Qu P; Roberts J; Li Y; Albrecht M; Cummings OW; Eble JN; Du H; Yan C
    Lung Cancer; 2009 Mar; 63(3):341-7. PubMed ID: 18614255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
    Kadivar M; Boozari B
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.
    Haneda H; Sasaki H; Lindeman N; Kawano O; Endo K; Suzuki E; Shimizu S; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Feb; 36(2):69-75. PubMed ID: 16449241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule.
    Nakano H; Soda H; Takasu M; Tomonaga N; Yamaguchi H; Nakatomi K; Fujino S; Hayashi T; Nakamura Y; Tsukamoto K; Kohno S
    Lung Cancer; 2008 Apr; 60(1):136-140. PubMed ID: 17889960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention.
    Karoubi G; Gugger M; Schmid R; Dutly A
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):393-7. PubMed ID: 19126554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 expression in activating EGFR-driven adenocarcinoma of the lung.
    Takata S; Takigawa N; Segawa Y; Kubo T; Ohashi K; Kozuki T; Teramoto N; Yamashita M; Toyooka S; Tanimoto M; Kiura K
    Lung Cancer; 2012 Jan; 75(1):24-9. PubMed ID: 21684622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
    Sarkaria IS; Pham D; Ghossein RA; Talbot SG; Hezel M; Dudas ME; Ebright MI; Chuai S; Memoli N; Venkatraman ES; Miller VA; Kris MG; Zakowski MF; Rusch VW; Singh B
    Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine Suppresses Lung Cancer Cell Proliferation Through the Interaction with Opioid Growth Factor Receptor: An In Vitro and Human Lung Tissue Study.
    Kim JY; Ahn HJ; Kim JK; Kim J; Lee SH; Chae HB
    Anesth Analg; 2016 Dec; 123(6):1429-1436. PubMed ID: 27167686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.
    Fujimoto J; Kadara H; Garcia MM; Kabbout M; Behrens C; Liu DD; Lee JJ; Solis LM; Kim ES; Kalhor N; Moran C; Sharafkhaneh A; Lotan R; Wistuba II
    J Thorac Oncol; 2012 Dec; 7(12):1747-1754. PubMed ID: 23154545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling of integrins in lung cancer cells.
    Guo L; Zhang F; Cai Y; Liu T
    Pathol Res Pract; 2009; 205(12):847-53. PubMed ID: 19674850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.